Header Logo

Connection

ANNE TSAO to Early Termination of Clinical Trials

Back to Details
This is a "connection" page, showing publications ANNE TSAO has written about Early Termination of Clinical Trials.
ANNE TSAO
Connection Strength
0.099
Early Termination of Clinical Trials
  1. Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma. J Thorac Oncol. 2011 Dec; 6(12):2104-11.
    View in: PubMed
    Score: 0.099
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.